Reading a Tirzepatide CoA: What Each Value Means
A Certificate of Analysis is the only document that connects a vial of lyophilized white powder to a defined molecular identity. For a 39-amino-acid lipidated peptide like tirzepatide, the CoA carries unusual weight: the synthesis is non-trivial, the molecular weight is large, and the lipid moiety introduces purification challenges that distinguish a research-grade lot from a sloppy one. This article walks through a tirzepatide CoA section by section in research context.
Tirzepatide is described here strictly for in vitro and animal-research use. The CoA-reading guidance is for researchers verifying the identity and purity of research material — not for any clinical, therapeutic, or human-use purpose.
Sample identifiers — the header block
Every research-grade CoA opens with sample identifiers:
- Compound name: Tirzepatide
- CAS Registry Number: 2023788-19-2
- Molecular formula: C₂₂₅H₃₄₈N₄₈O₆₈
- Theoretical molecular weight: ~4813.5 g/mol (free acid)
- Lot number: Unique to the synthesis batch
- Manufacturing date and expiration: Both should appear
Cross-check the CAS against published references (PubChem CID 156588324 is the standard reference entry). The molecular formula calculation is also worth confirming if the researcher is being thorough — a single residue substitution in synthesis would shift the formula in characteristic ways.
HPLC purity
This is the single most informative number on the CoA. For tirzepatide, the acceptable threshold is ≥99.0% by area on a reversed-phase HPLC chromatogram. The chromatogram itself should appear on the CoA, not just the summary number.
What to look for in the trace:
– A single dominant peak corresponding to the tirzepatide main band, typically at the retention time documented on the method conditions.
– Any minor peaks below 1.0% area should be characterized where possible. For a lipidated peptide, common impurities include deletion sequences (one or more amino acids missing), incomplete fatty-acid conjugation products, and oxidation byproducts.
– An “unknown impurity” cluster above 1% is a yellow flag — ask the vendor for mass-spec characterization of the unknown.
A CoA reporting only “≥99%” with no chromatogram is incomplete. A research-grade vendor publishes the trace.
Mass spectrometry confirmation
The mass spec section establishes molecular identity. For tirzepatide:
– Expected [M+H]⁺: ~4814.5 Da
– Observed mass should fall within ±0.5 Da of theoretical
– Multi-charge ions ([M+2H]²⁺ at ~2407.8, [M+3H]³⁺ at ~1605.5, [M+4H]⁴⁺ at ~1204.4) should be visible at expected m/z positions
For a peptide this size, higher-charge-state ions are typically more informative than [M+H]⁺ alone because the isotope envelope resolves better at lower m/z values. The CoA should show the deconvoluted spectrum with the assigned monoisotopic mass.
If the observed mass is off by 18 Da, hydrolysis somewhere in the chain is the likely culprit. If it is off by 16 Da, methionine or tryptophan oxidation is the common explanation. Larger discrepancies suggest sequence errors.
Net peptide content
Lyophilized peptide vials contain peptide mass plus counterion salts (typically acetate or trifluoroacetate) plus residual moisture. The label may read “10 mg,” but the net peptide content — the actual peptide mass — is typically 85–92% of the gross.
A research-grade CoA reports:
– Net peptide content (%), determined by amino acid analysis or nitrogen content
– Counterion identity and content
– Residual moisture by Karl Fischer titration
For tirzepatide reconstitution math, the net peptide content matters. If the vial is labeled 10 mg gross with a CoA net of 88%, the deliverable peptide mass is 8.8 mg. Reconstitution volume calculations should always reference net content, not gross mass.
For the broader reconstitution math discussion, see the how to read a peptide CoA guide.
Counterion identification
Tirzepatide synthesis routes typically end with acetate counterion exchange. Trifluoroacetate (TFA) residues from purification steps should be either replaced or reported. The CoA should specify which counterion is present and at what level. TFA above ~1% in cell-culture-grade material is a concern; in animal-research applications it can confound downstream measurements.
Amino acid sequence and modification confirmation
A thorough CoA documents the amino acid sequence and, for a modified peptide like tirzepatide, the specific position and identity of the lipid modification. The C20 fatty diacid linked via γGlu-2xAEEA at lysine-20 should be explicitly named. Sequence confirmation methods include automated Edman degradation, amino acid analysis, or tandem MS sequencing.
If the CoA omits sequence information entirely, the researcher is taking the vendor’s word for it. For a 39-residue peptide, that’s a significant act of trust.
Endotoxin and bioburden
For cell-culture or animal-injection research, endotoxin limits become important. Standard research-grade tirzepatide CoAs may not include endotoxin testing by default; request it from the vendor if the application requires it. Bioburden (total aerobic count, total mold/yeast count) is similarly application-dependent.
Lot traceability
The lot number printed on the vial must resolve to the CoA document. Any reputable research-supply vendor should publish the CoA per lot; verify that the lot number on the vial resolves to a downloadable PDF before use., where the lot number on the vial corresponds to a downloadable PDF. Lot traceability is the bridge between a physical vial and a reproducible experiment.
Red flags on a tirzepatide CoA
Quick-reject conditions for a tirzepatide CoA:
– No HPLC chromatogram, only a summary number
– Mass spectrum absent or unreadable
– “Net peptide content” missing — only gross mass reported
– Counterion not identified
– Lot number not traceable to vendor’s verification system
– Purity reported as “≥95%” rather than ≥99% — acceptable for some research peptides, low for tirzepatide
Summary
A tirzepatide CoA is a multi-section document, and each section answers a specific question. HPLC purity establishes how much of the lot is the target compound. Mass spectrometry confirms molecular identity. Net peptide content corrects gross-mass labeling for reconstitution math. Counterion identification informs downstream compatibility. Sequence confirmation closes the loop on identity.
Research Use Only. Not for use in or on humans or animals. Not a food, drug, cosmetic, or supplement.